During the recent session, MiNK Therapeutics Inc (NASDAQ:INKT)’s traded shares were 17.59 million, with the beta value of the company hitting 0.19. At the last check today, the stock’s price was $56.25, reflecting an intraday gain of 627.68% or $48.52. The 52-week high for the INKT share is $13.79, that puts it up 75.48 from that peak though still a striking 91.89% gain since the share price plummeted to a 52-week low of $4.56. The company’s market capitalization is $224.20M, and the average intraday trading volume over the past 10 days was 2600.0 shares, and the average trade volume was 7.55K shares over the past three months.
MiNK Therapeutics Inc (NASDAQ:INKT) trade information
MiNK Therapeutics Inc (INKT) registered a 627.68% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 627.68% in intraday trading to $56.25, hitting a weekly high. The stock’s 5-day price performance is 677.86%, and it has moved by 642.26% in 30 days. Based on these gigs, the overall price performance for the year is 707.15%. The short interest in MiNK Therapeutics Inc (NASDAQ:INKT) is 10657.0 shares and it means that shorts have 2.44 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 16.86%. While earnings are projected to return 30.94% in 2025, the next five years will return 15.43% per annum.
INKT Dividends
MiNK Therapeutics Inc is due to release its next quarterly earnings on 2025-May-15. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
MiNK Therapeutics Inc (NASDAQ:INKT)’s Major holders
MiNK Therapeutics Inc insiders own 74.40% of total outstanding shares while institutional holders control 1.58%, with the float percentage being 6.17%. VANGUARD GROUP INC is the largest shareholder of the company, while 22.0 institutions own stock in it. As of 2024-06-30, the company held over 0.23 million shares (or 0.676% of all shares), a total value of $0.22 million in shares.
The next largest institutional holding, with 0.17 million shares, is of LONGBOW FINANCE SA’s that is approximately 0.4811% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.16 million.
Also, the Mutual Funds coming in first place with the largest holdings of MiNK Therapeutics Inc (INKT) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 15.15 shares. This amounts to just over 0.38 percent of the company’s overall shares, with a $0.83 million market value. The same data shows that the other fund manager holds slightly less at 8.6, or about 0.22% of the stock, which is worth about $0.47 million.
